L. Boussofara
Impact in
- Microbiology top 10%
- Dermatology top 10%
- Contact Dermatitis and Allergies
Papers in
-
- Autoimmune Bullous Skin Diseases 10
- Tumors and Oncological Cases 4
- Epidemiology 14
- Autoimmune and Inflammatory Disorders 6
- Co-authors
- M. Denguezli (44 shared papers)C. Belajouza (26 shared papers)R. Nouira (12 shared papers)Badreddine Sriha (13 shared papers)R. Nouira (19 shared papers)Neila Fathallah (4 shared papers)Raoudha Slim (3 shared papers)Kamel Bouraoui (1 shared paper)
In The Last Decade
L. Boussofara
38 papers receiving 184 citations
Peers
Comparison fields: 5 of 41
- Microbiology 11
- Dermatology 45
- Toxicology 8
- Pharmacology 38
- Urology 13
Countries citing papers authored by L. Boussofara
This map shows the geographic impact of L. Boussofara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Boussofara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Boussofara more than expected).
Fields of papers citing papers by L. Boussofara
This network shows the impact of papers produced by L. Boussofara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Boussofara. The network helps show where L. Boussofara may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Boussofara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 18 | |
| 2 | 2011 | 16 | |
| 3 | 2021 | 15 | |
| 4 | 2019 | 13 | |
| 5 | 2012 | 11 | |
| 6 | 2008 | 11 | |
| 7 | 2015 | 10 | |
| 8 | 2010 | 9 | |
| 9 | 2023 | 9 | |
| 10 | 2007 | 7 | |
| 11 | 2018 | 7 | |
| 12 | 2013 | 6 | |
| 13 | 2022 | 5 | |
| 14 | 2007 | 5 | |
| 15 | 2018 | 4 | |
| 16 | 2018 | 4 | |
| 17 | Bilateral idiopathic hyperkeratosis of the nipple and areola. | 2011 | 4 |
| 18 | 2015 | 3 | |
| 19 | 2011 | 3 | |
| 20 | 2014 | 3 |
About L. Boussofara
L. Boussofara is a scholar working on Pathology and Forensic Medicine, Epidemiology, Dermatology, Genetics and Rheumatology, having authored 50 papers that have together received 191 indexed citations. Recurring topics across this work include Autoimmune Bullous Skin Diseases (10 papers), Drug-Induced Adverse Reactions (6 papers), Genetic and rare skin diseases. (6 papers), Autoimmune and Inflammatory Disorders (6 papers), Dermatological and Skeletal Disorders (4 papers), Urticaria and Related Conditions (4 papers), Cancer and Skin Lesions (4 papers) and Tumors and Oncological Cases (4 papers). The work is most often cited by research in Microbiology (11 citations), Dermatology (45 citations), Toxicology (8 citations), Pharmacology (38 citations) and Urology (13 citations). L. Boussofara has collaborated with scholars based in Tunisia, Singapore and France. Frequent co-authors include M. Denguezli, C. Belajouza, R. Nouira, Badreddine Sriha, R. Nouira, Neila Fathallah, Raoudha Slim, Kamel Bouraoui, Ali Saâd and Amel Mebazâa. Their work appears in journals such as Annales de Dermatologie et de Vénéréologie, Pediatric Dermatology, Contact Dermatitis, Frontiers in Immunology and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.